...
首页> 外文期刊>Annals of hematology >Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation
【24h】

Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation

机译:同种异体造血干细胞移植术后患者颅内出血的临床特征和危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Intracranial hemorrhage (ICH) is one of the most life-threatening neurological complications after allogeneic hematopoietic stem cell transplantation. Although cerebral complications and its causes after allo-HSCT are well documented, assessment of the incidence and risk factors of intracranial hemorrhage following allo-HSCT are less discussed. A nested case-control study was conducted involving 160 subjects drawn from 2169 subjects who underwent HSCT at Peking University People's Hospital between 2004 and 2014. Thirty-two patients (1.5 %) with ICH were identified, and 128 controls were matched for age, gender, transplantation type, and time of transplantation. Intracranial hemorrhage was identified by CT scan and/or MRI by searching hospital records. Among the 32 ICH patients, 27 (82.9 %) developed intraparenchymal hemorrhages (IPH), 2 cases (5.7 %) suffered subdural hematomas (SDH), and 3 cases (8.6 %) had multiple hemorrhage lesions in the brain parenchyma. The median time of appearance for cerebral hemorrhages was 147.5 days. Multivariate analysis showed that systemic infections (hazard ratio 2.882, 95 % confidence interval 1.231-6.746), platelet count (5.894, 1.145-30.339), and fibrinogen levels (3.611, 1.528-8.532) were independent risk factors for intracranial hemorrhage among HSCT patients. The cumulative survival rate in the intracranial hemorrhage and control groups were 43.3 and 74.7 % (P = .001), respectively. Intracranial hemorrhage is associated with high mortality and a decreased overall survival rate. Systemic infections, platelet count, and fibrinogen levels were individual independent risk factors.
机译:异基因造血干细胞移植后,颅内出血(ICH)是最致命的神经系统并发症之一。尽管异基因造血干细胞移植术后脑部并发症及其病因已得到了充分的文献记载,但异基因造血干细胞移植术后颅内出血的发生率和危险因素的评估却很少讨论。进行了一项嵌套的病例对照研究,研究对象是2004年至2014年在北京大学人民医院接受HSCT的2169名受试者中的160名受试者。确定了32例ICH患者(1.5%),并匹配了128名对照者的年龄,性别,移植类型和移植时间。通过搜索医院记录通过CT扫描和/或MRI识别颅内出血。在32例ICH患者中,有27例(82.9%)发生了实质性内出血(IPH),2例(5.7%)发生了硬膜下血肿(SDH),3例(8.6%)出现了脑实质多发性出血。脑出血出现的中位时间为147.5天。多因素分析显示,系统性感染(危险比2.882,95%置信区间1.231-6.746),血小板计数(5.894、1.145-30.339)和纤维蛋白原水平(3.611、1.528-8.532)是HSCT患者颅内出血的独立危险因素。 。颅内出血和对照组的累积生存率分别为43.3%和74.7%(P = .001)。颅内出血与高死亡率和降低的总生存率有关。全身感染,血小板计数和纤维蛋白原水平是独立的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号